These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1235480)

  • 1. Viral hepatitis type B: prospects for active immunization.
    Krugman S
    Am J Med Sci; 1975; 270(2):391-3. PubMed ID: 1235480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral hepatitis type B: propects for active immunization.
    Krugman S
    Dev Biol Stand; 1975; 30():363-7. PubMed ID: 1204971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subunit, recombinant and synthetic hepatitis B vaccines.
    Zuckerman AJ
    Scand J Gastroenterol Suppl; 1985; 117():27-38. PubMed ID: 3912963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B immunity in hospital staff targeted for vaccination. Role of screening tests in immunization programs.
    Grady GF
    JAMA; 1982 Nov; 248(18):2266-9. PubMed ID: 7131678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen.
    Krugman S; Hoofnagle JH; Gerety RJ; Kaplan PM; Gerin JL
    N Engl J Med; 1974 Jun; 290(24):1331-5. PubMed ID: 4827643
    [No Abstract]   [Full Text] [Related]  

  • 6. Viral hepatitis, type B. Studies on natural history and prevention re-examined.
    Krugman S; Overby LR; Mushahwar IK; Ling CM; Frösner GG; Deinhardt F
    N Engl J Med; 1979 Jan; 300(3):101-6. PubMed ID: 758598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Active immunization against hepatitis B].
    Wildgrube HJ; Classen M; von Lohr R; Kurth R; Brede HD
    Dtsch Med Wochenschr; 1984 Feb; 109(7):246-50. PubMed ID: 6230216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of active preventive vaccination against hepatitis B with a German vaccine].
    Henning H; Laufs R; Kätzner K; Bredehorst R
    Z Gastroenterol; 1983 Mar; 21(3):111-4. PubMed ID: 6868717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hbc ag, anti-HBC, and DNA polymerase activity in transfused recipients followed prospectively.
    Hollinger FB; Dressman GR; Fields H; Melnick J
    Am J Med Sci; 1975; 270(2):343-8. PubMed ID: 1235476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
    Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
    Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response in neonates to hepatitis B vaccine.
    Barin F; Goudeau A; Denis F; Yvonnet B; Chiron JP; Coursaget P; Mar ID
    Lancet; 1982 Jan; 1(8266):251-3. PubMed ID: 6120276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type B hepatitis: a review of current prospects for a safe and effective vaccine.
    McAuliffe VJ; Purcell RH; Gerin JL
    Rev Infect Dis; 1980; 2(3):470-92. PubMed ID: 6997970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoprevention of hepatitis B in children].
    Kätzner K; Laufs R
    Monatsschr Kinderheilkd; 1984 Feb; 132(2):124-5. PubMed ID: 6727883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions.
    Steward MW; Sisley BM; Stanley C; Brown SE; Howard CR
    Clin Exp Immunol; 1988 Jan; 71(1):19-25. PubMed ID: 3349646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization against hepatitis B--what can we expect? Results of a survey of antibody response to immunization in persons 'at risk' of occupational exposure to hepatitis B.
    Westmoreland D; Player V; Heap DC; Hammond A
    Epidemiol Infect; 1990 Jun; 104(3):499-509. PubMed ID: 2140795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.
    Dusheiko GM; Hoofnagle JH; Cooksley WG; James SP; Jones EA
    J Clin Invest; 1983 May; 71(5):1104-13. PubMed ID: 6602149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of hepatitis B vaccine in chimpanzees given transfusions of highly infective blood.
    Karasawa T; Shikata T; Abe K; Horiuchi R; Takahashi T; Yoshihara N; Mayumi M; Suzuki H; Oda T
    J Infect Dis; 1983 Feb; 147(2):327-35. PubMed ID: 6827148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous administration of inactivated hepatitis B vaccine by automatic jet injection.
    Lemon SM; Scott RM; Bancroft WH
    J Med Virol; 1983; 12(2):129-36. PubMed ID: 6619812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus exposure during childhood in Cameroon, Central African Republic and Senegal after the integration of HBV vaccine in the expanded program on immunization.
    Rey-Cuille MA; Njouom R; Bekondi C; Seck A; Gody C; Bata P; Garin B; Maylin S; Chartier L; Simon F; Vray M
    Pediatr Infect Dis J; 2013 Oct; 32(10):1110-5. PubMed ID: 23694839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.